Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 39, 42-52
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Current approaches for identifying high-risk non-muscle invasive bladder cancerExpert Review of Anticancer Therapy, 2018
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016European Urology, 2017
- Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancerMolecular Medicine Reports, 2016
- Downregulation of fatty acid synthase complex suppresses cell migration by targeting phospho-AKT in bladder cancerMolecular Medicine Reports, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosisJournal of Neuro-Oncology, 2014
- Fatty Acid Synthase Mediates the Epithelial-Mesenchymal Transition of Breast Cancer CellsInternational Journal of Biological Sciences, 2014
- Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladderBritish Journal of Cancer, 2013
- Nutrient-dependent phosphorylation channels lipid synthesis to regulate PPARαJournal of Lipid Research, 2013
- Fatty Acid Synthase Regulates Proliferation and Migration of Colorectal Cancer Cells Via HER2-PI3K/Akt Signaling PathwayNutrition and Cancer, 2012